{"id":"W1542077310","doi":"10.1002/acr.20331","title":"American College of Rheumatology hybrid analysis of certolizumab pegol plus methotrexate in patients with active rheumatoid arthritis: Data from a 52‐week phase III trial","year":2010,"lang":"en","type":"article","venue":"Arthritis Care & Research","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; European League Against Rheumatism; Bristol-Myers Squibb","keywords":"Certolizumab pegol; Rheumatoid arthritis; Medicine; Internal medicine; Placebo; Rheumatology; Methotrexate; Post-hoc analysis; Randomized controlled trial; Adalimumab; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004592965,0.001024715,0.00223259,0.0002968241,0.0003957213,0.001048621,0.0006068954,0.001045049,0.003496059],"category_scores_gemma":[0.00248308,0.0003656791,0.002070332,0.0004612159,0.0006392212,0.0006867233,0.0003572094,0.002219701,0.0005919298],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004713275,"about_ca_system_score_gemma":0.0009095052,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006555595,"about_ca_topic_score_gemma":0.001620991,"domain_scores_codex":[0.9980456,0.001257461,0.0001406876,0.0002029727,0.0001948638,0.0001584869],"domain_scores_gemma":[0.9975551,0.0006955513,0.0006516915,0.0002869813,0.0002227558,0.0005880382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9351627,0.00650842,0.004809633,0.0009621065,0.004981221,0.0000829505,0.00007795831,0.0007953162,0.005381838,0.0001066532,0.002137106,0.03899401],"study_design_scores_gemma":[0.9021137,0.07898376,0.01428496,0.00005670275,0.001856376,0.0001338865,0.00002243644,0.0005032706,0.0005881467,0.00008861098,0.001344375,0.00002382193],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9782638,0.0144109,0.0008142931,0.0009564278,0.0002659856,0.001244733,0.001242709,0.00009024856,0.002710907],"genre_scores_gemma":[0.9900636,0.003595496,0.001153732,0.0008137565,0.0003143035,0.001281019,0.001455405,0.00001943135,0.00130326],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004592965,"threshold_uncertainty_score":0.02429026,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03532601163582024,"score_gpt":0.3591764957934849,"score_spread":0.3238504841576647,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}